Logo image of FLGC

FLORA GROWTH CORP (FLGC) Stock Fundamental Analysis

NASDAQ:FLGC - CA3397642016 - Common Stock

22.71 USD
+2.26 (+11.05%)
Last: 9/2/2025, 8:02:43 PM
Fundamental Rating

1

Taking everything into account, FLGC scores 1 out of 10 in our fundamental rating. FLGC was compared to 36 industry peers in the Personal Care Products industry. FLGC has a bad profitability rating. Also its financial health evaluation is rather negative. FLGC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year FLGC has reported negative net income.
FLGC had a negative operating cash flow in the past year.
FLGC had negative earnings in each of the past 5 years.
FLGC had a negative operating cash flow in each of the past 5 years.
FLGC Yearly Net Income VS EBIT VS OCF VS FCFFLGC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

FLGC has a Return On Assets of -59.35%. This is amonst the worse of the industry: FLGC underperforms 86.11% of its industry peers.
FLGC has a worse Return On Equity (-279.34%) than 80.56% of its industry peers.
Industry RankSector Rank
ROA -59.35%
ROE -279.34%
ROIC N/A
ROA(3y)-122.26%
ROA(5y)-92.9%
ROE(3y)-445.2%
ROE(5y)-289.95%
ROIC(3y)N/A
ROIC(5y)N/A
FLGC Yearly ROA, ROE, ROICFLGC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 2K 4K 6K

1.3 Margins

The Gross Margin of FLGC (25.41%) is worse than 77.78% of its industry peers.
FLGC's Gross Margin has declined in the last couple of years.
FLGC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.89%
GM growth 5YN/A
FLGC Yearly Profit, Operating, Gross MarginsFLGC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K -10K

More info and screens

2

2. Health

2.1 Basic Checks

FLGC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, FLGC has more shares outstanding
Compared to 5 years ago, FLGC has more shares outstanding
Compared to 1 year ago, FLGC has an improved debt to assets ratio.
FLGC Yearly Shares OutstandingFLGC Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100K 200K 300K 400K
FLGC Yearly Total Debt VS Total AssetsFLGC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -8.83, we must say that FLGC is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of FLGC (-8.83) is worse than 94.44% of its industry peers.
FLGC has a Debt/Equity ratio of 0.43. This is a healthy value indicating a solid balance between debt and equity.
FLGC has a Debt to Equity ratio (0.43) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF N/A
Altman-Z -8.83
ROIC/WACCN/A
WACC8.81%
FLGC Yearly LT Debt VS Equity VS FCFFLGC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

FLGC has a Current Ratio of 1.05. This is a normal value and indicates that FLGC is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of FLGC (1.05) is worse than 72.22% of its industry peers.
FLGC has a Quick Ratio of 1.05. This is a bad value and indicates that FLGC is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.67, FLGC is doing worse than 72.22% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 0.67
FLGC Yearly Current Assets VS Current LiabilitesFLGC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

3

3. Growth

3.1 Past

FLGC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -676.32%.
The Revenue for FLGC has decreased by -21.78% in the past year. This is quite bad
Measured over the past years, FLGC shows a very strong growth in Revenue. The Revenue has been growing by 87.83% on average per year.
EPS 1Y (TTM)-676.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2045%
Revenue 1Y (TTM)-21.78%
Revenue growth 3Y87.83%
Revenue growth 5YN/A
Sales Q2Q%-5.66%

3.2 Future

The Earnings Per Share is expected to grow by 2.98% on average over the next years.
The Revenue is expected to grow by 0.39% on average over the next years.
EPS Next Y54.37%
EPS Next 2Y2.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-8.56%
Revenue Next 2Y0.39%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
FLGC Yearly Revenue VS EstimatesFLGC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
FLGC Yearly EPS VS EstimatesFLGC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -100 -200 -300 -400

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for FLGC. In the last year negative earnings were reported.
Also next year FLGC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FLGC Price Earnings VS Forward Price EarningsFLGC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FLGC Per share dataFLGC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.98%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for FLGC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FLORA GROWTH CORP

NASDAQ:FLGC (9/2/2025, 8:02:43 PM)

22.71

+2.26 (+11.05%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)08-01 2025-08-01/amc
Earnings (Next)11-12 2025-11-12
Inst Owners3.96%
Inst Owner Change1.47%
Ins Owners12.7%
Ins Owner Change0%
Market Cap13.17M
Analysts82.5
Price Target94.86 (317.7%)
Short Float %N/A
Short Ratio0.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-346.11%
Min EPS beat(2)-426.8%
Max EPS beat(2)-265.42%
EPS beat(4)0
Avg EPS beat(4)-308.58%
Min EPS beat(4)-426.8%
Max EPS beat(4)-206.37%
EPS beat(8)1
Avg EPS beat(8)-455.41%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-14.3%
Min Revenue beat(2)-25.05%
Max Revenue beat(2)-3.55%
Revenue beat(4)0
Avg Revenue beat(4)-20.38%
Min Revenue beat(4)-27.06%
Max Revenue beat(4)-3.55%
Revenue beat(8)2
Avg Revenue beat(8)-12%
Revenue beat(12)2
Avg Revenue beat(12)-10.82%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3281.82%
PT rev (3m)2225%
EPS NQ rev (1m)-3800%
EPS NQ rev (3m)-11800%
EPS NY rev (1m)-142.86%
EPS NY rev (3m)-828.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)2.85%
Revenue NY rev (3m)2.85%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.25
P/FCF N/A
P/OCF N/A
P/B 2.77
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-8.85
EYN/A
EPS(NY)-1.07
Fwd EYN/A
FCF(TTM)-11.19
FCFYN/A
OCF(TTM)-11.07
OCFYN/A
SpS91.83
BVpS8.2
TBVpS-4.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -59.35%
ROE -279.34%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.41%
FCFM N/A
ROA(3y)-122.26%
ROA(5y)-92.9%
ROE(3y)-445.2%
ROE(5y)-289.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.89%
GM growth 5YN/A
F-Score3
Asset Turnover2.38
Health
Industry RankSector Rank
Debt/Equity 0.43
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 7.99%
Cap/Sales 0.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 0.67
Altman-Z -8.83
F-Score3
WACC8.81%
ROIC/WACCN/A
Cap/Depr(3y)24.35%
Cap/Depr(5y)215.63%
Cap/Sales(3y)1.3%
Cap/Sales(5y)51.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-676.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2045%
EPS Next Y54.37%
EPS Next 2Y2.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-21.78%
Revenue growth 3Y87.83%
Revenue growth 5YN/A
Sales Q2Q%-5.66%
Revenue Next Year-8.56%
Revenue Next 2Y0.39%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-18.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year33.17%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y56.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y53.14%
OCF growth 3YN/A
OCF growth 5YN/A